Human Immunology
短名 | Hum. Immunol. |
Journal Impact | 2.90 |
国际分区 | IMMUNOLOGY(Q3) |
期刊索引 | SCI Q4中科院 4 区 |
ISSN | 0198-8859, 1879-1166 |
h-index | 103 |
国内分区 | 医学(4区)医学免疫学(4区) |
该杂志的范围包括了解人类个体对同种异体移植物、怀孕、感染或疫苗的免疫反应以及导致自身免疫、过敏或药物超敏反应的免疫反应的遗传和功能机制。它还包括检查分布研究领域包括:免疫相关基因的遗传学、基因组学、多态性、进化和种群分布研究免疫相关基因产物的表达、结构和功能研究易感性的免疫遗传学感染性和自身免疫性疾病和过敏免疫相关基因在造血干细胞、实体器官和带血管的复合同种异体移植中的作用组织相容性研究,包括同种异体抗体、表位定义和 T 细胞同种异体反应免疫耐受性和妊娠的研究 T 细胞、B 细胞、NK 和调节细胞乐趣行动,特别是与期刊范围内的主题相关的药物基因组学和免疫相关基因背景下的疫苗开发人类免疫学认为免疫相关基因包括那些编码经典和非经典 HLA、KIR、MIC、次要组织相容性抗原 (MHAG) 的基因、免疫球蛋白、TCR、BCR、参与抗原加工和呈递的蛋白质、补体、FC受体、趋化因子和细胞因子。可以考虑其他免疫相关基因。人类免疫学还对免疫相关基因的生物信息学和影响实验室过程、器官分配、临床策略和与自身免疫和移植相关的登记的组织主题感兴趣。
期刊主页投稿网址涉及主题 | 生物医学遗传学免疫学化学生物化学抗原基因人类白细胞抗原内科学等位基因抗体计算机科学免疫系统基因型病理外科 |
出版信息 | 出版商: Elsevier Inc.,出版周期: Monthly,期刊类型: journal |
基本数据 | 创刊年份: 1980,原创研究文献占比: 86.00%,自引率:3.20%, Gold OA占比: 18.02% |
平均审稿周期 | 网友分享经验:平均1.5月来源Elsevier官网:平均17.1周 |
平均录用比例 | 网友分享经验:约50% |
期刊引文格式
这些示例是对学术期刊文章的引用,以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章,因此这些字段是可选的。有些电子期刊不提供页面范围,而是列出文章标识符。在这种情况下,使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用,以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
Polymorphisms in genes involved in regulating follicular helper T cell differentiation predict de novo donor-specific antibody formation after liver transplantation
2024-11-1
B cells enhance EphA2 chimeric antigen receptor T cells cytotoxicity against glioblastoma via improving persistence
2024-11-1
Harnessing the potential of red blood cells in immunotherapy
2024-11-1
Elevated toll-like receptor 9 is associated with disease severity and kidney involvement in systemic lupus erythematosus
2024-11-1
Clinical features and prognostic factors in elderly patients with sepsis in the emergency intensive care unit
2024-11-1
Enrichment analysis of systemic lupus erythematosus susceptible loci identified by genome-wide association studies
2024-9-18
Hiding in plain sight: Misinterpretation of immunogenic DPB epitopes within G/P groups. Short running title: The impact of HLA G and P codes on DPB
2024-9-14
Identification of highly conserved surface-exposed peptides of spike protein for multiepitope vaccine design against emerging omicron variants: An immunoinformatic approach
2024-9-13
Denovo granulocyte–macrophage colony-stimulating factor antibody production has been linked to acute graft-versus-host disease following hematopoietic stem cell transplantation from an HLA-matched, unrelated donor
2024-9-13
Seroconversion in liver and intestine transplant patients after one, two or three doses of adenoviral vector vaccines against SARS-CoV-2. Single center experience in Argentina
2024-9-11
HLA class-I polymorphisms among the Punjabi population of Pakistan: A comparative analysis with country’s other ethnic groups
2024-9-1
Establishment of T cell and B cell flow cytometric xenocrossmatching test
2024-9-1
Identification of non-HLA autoantibodies associated with biopsy-proven rejection in kidney transplantation
2024-9-1
Varying potency of self/cancer peptides in KIR3DL1 recognition of HLA-A*24:02
2024-9-1
Protein losing enteropathy may pose a hidden danger to prospective heart transplant patients
2024-9-1
Analysis of non-consensus antibodies observed in the ASHI-PT survey
2024-9-1
High-throughput, high-resolution HLA typing using NGS-Pronto nanopore sequencing – a multicentre performance study
2024-9-1
HLA tissue typing and histocompatibility in supporting the Australian uterus transplant program
2024-9-1
Comparison of two Elisa-based Angiotensin II-type-1 receptor (AT1R) autoantibody detection assays using an antibody cross-reactivity check approach
2024-9-1
Rare DRB1*01 with DRB5 haplotype
2024-9-1
Troubleshooting apparent allelic dropout using two methods: of next generation sequencing
2024-9-1
How many clinical histocompatibility and immunogenetics laboratories are there in the world? A glance at their geographical distribution and accreditation
2024-9-1
KIR3DL1*004 is associated with Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS)
2024-9-1
HLA-DQ heterodimer mismatch number is associated with de novo donor-specific antibody development in pediatric kidney transplant recipients
2024-9-1
Chimerism testing for postmortem evaluation of solid organ and transfusion associated graft-vs-host disease
2024-9-1
39-year-old postpartum G3P2 heart transplant patient with rapid antibody response
2024-9-1
Investigating HLA-DRB1 genotypes as contributing risk factors for Staphylococcus aureus bacteremia
2024-9-1
Harnessing the power of immunoinformatics: Characterizing the role of T-cell immunity as an integral part of vaccine development and efficacy testing regimen
2024-9-1
To list or not to list; A case of a highly sensitized kidney after liver transplant candidate
2024-9-1
Using PreSorb and MagSort to characterize pan-DR sera
2024-9-1
Synergistic effect of DSA and non-HLA antibodies on T cell-mediated rejection of adult liver allografts
2024-9-1
New method: For evaluating deviation from Hardy-Weinberg Equilibrium in large, real world HLA datasets
2024-9-1
The use of business intelligence software to promote quality and service excellence of laboratory operations
2024-9-1
A novel assay to accurately measure TorqueTenovirus load for immunosuppression level monitoring in transplant recipients
2024-9-1
Population study to define HLA in Mohawk First Nation in Quebec
2024-9-1
Novel null allele discovered by rapid next-gen sequencing
2024-9-1
Evaluating Daratumumab in the treatment of antibody mediated rejection in pediatric heart transplantation
2024-9-1
DR53 antibody positivity study: 50% or 0% cPRA
2024-9-1
Virtual crossmatch (VXM) by the numbers
2024-9-1
Uncovering the rarity: DR7-DR53-DQ9 haplotype in two Caucasian patients
2024-9-1
Population study to define HLA in Wendat First Nation in Quebec
2024-9-1
LILR full gene variation in European and African American cohorts
2024-9-1
Sensitive and fast NGS-based chimerism monitoring using ONT sequencing
2024-9-1
Novel desensitization strategy in a highly sensitized heart/liver transplant candidate using imlifidase
2024-9-1
KIR2DL1*001/HLA-C2 is associated with risk for multiple sclerosis
2024-9-1
Risk of kidney graft failure (GF) associated with HLA class II amino acid mismatches (AAMM) is highest during the first year after transplant for sensitized patients
2024-9-1
Apparent maternal exclusion explained by a MICA deletion
2024-9-1
Differential adsorption of HLA and non-HLA antibodies following combined liver and kidney transplantation
2024-9-1
Characterization of a De Novo recipient-specific anti-HLA antibody following a second haploidentical transplant
2024-9-1
Positive flow crossmatches due to anti-ABO red blood cell antibodies
2024-9-1
帮你贴心管理全部的文献
研飞ivySCI,高效的论文管理
投稿经验分享
分享我的经验,帮你走得更远